Ming Xiao Selected Research

ADP Ribose Transferases (ADP Ribosyltransferase)

10/2018	Effects of β-caryophyllene on arginine ADP-ribosyltransferase 1-mediated regulation of glycolysis in colorectal cancer under high-glucose conditions.
3/2016	Arginine ADP-ribosyltransferase 1 promotes angiogenesis in colorectal cancer via the PI3K/Akt pathway.
2/2016	Tubb3 regulation by the Erk and Akt signaling pathways: a mechanism involved in the effect of arginine ADP-ribosyltransferase 1 (Art1) on apoptosis of colon carcinoma CT26 cells.
1/2015	ART1 promotes starvation-induced autophagy: a possible protective role in the development of colon carcinoma.
7/2013	Inhibition of arginine ADP-ribosyltransferase 1 reduces the expression of poly(ADP-ribose) polymerase-1 in colon carcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ming Xiao Research Topics

Disease

32	Neoplasms (Cancer) 01/2022 - 12/2005
19	Alzheimer Disease (Alzheimer's Disease) 09/2022 - 04/2007
11	Neuroinflammatory Diseases 01/2022 - 08/2013
10	Cognitive Dysfunction 01/2022 - 04/2012
9	Carcinoma (Carcinomatosis) 06/2020 - 01/2013
7	Inflammation (Inflammations) 12/2021 - 01/2016
6	Colorectal Neoplasms (Colorectal Cancer) 01/2022 - 10/2004
5	Atrophy 08/2016 - 10/2008
4	Infections 01/2018 - 01/2011
3	Neoplasm Metastasis (Metastasis) 10/2020 - 01/2019
3	Parkinson Disease (Parkinson's Disease) 08/2020 - 11/2018
3	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 02/2019 - 01/2016
3	Amyloid Plaque 08/2016 - 08/2013
3	Gliosis 05/2014 - 08/2010
2	Myocardial Infarction 05/2022 - 01/2018
2	Hypertrophy 01/2022 - 12/2016
2	Glioblastoma (Glioblastoma Multiforme) 01/2022 - 09/2020
2	Spinal Cord Injuries (Spinal Cord Injury) 01/2022 - 07/2021
2	Breast Neoplasms (Breast Cancer) 01/2022 - 02/2015
2	Neurodegenerative Diseases (Neurodegenerative Disease) 12/2021 - 08/2020
2	Carcinogenesis 08/2021 - 05/2017
2	Necrosis 12/2019 - 01/2018
2	Brain Ischemia (Cerebral Ischemia) 02/2019 - 01/2015
2	Hypercholesterolemia 06/2018 - 04/2012
2	Ischemia 01/2018 - 01/2016
2	Hypertension (High Blood Pressure) 01/2018 - 02/2015
2	Ischemic Stroke 01/2016 - 01/2016
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 06/2013 - 12/2012
2	Pain (Aches) 11/2012 - 04/2006
2	Inborn Genetic Diseases (Disease, Hereditary) 07/2012 - 10/2010
2	Memory Disorders (Memory Loss) 04/2012 - 02/2012
2	Mitochondrial Diseases (Mitochondrial Disease) 08/2010 - 03/2010
2	Diarrhea 12/2009 - 02/2006
1	Abnormal Reflex (Hyperreflexia) 01/2022
1	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2022
1	Hemolytic Anemia 02/2021
1	Thrombosis (Thrombus) 02/2021
1	Thrombocytopenia (Thrombopenia) 02/2021
1	Disseminated Intravascular Coagulation 02/2021

Drug/Important Bio-Agent (IBA)

21	Proteins (Proteins, Gene)FDA Link 09/2022 - 12/2009
9	Amyloid beta-PeptidesIBA 09/2022 - 08/2015
6	RNA (Ribonucleic Acid)IBA 01/2022 - 10/2004
6	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2009
6	Aquaporins (Water Channels)IBA 01/2020 - 04/2012
6	Arginine (L-Arginine)FDA Link 10/2018 - 07/2013
6	Galactose (Galactopyranose)FDA LinkGeneric 06/2014 - 04/2007
5	Messenger RNA (mRNA)IBA 01/2021 - 10/2004
5	Small Interfering RNA (siRNA)IBA 12/2019 - 01/2013
5	ADP Ribose Transferases (ADP Ribosyltransferase)IBA 10/2018 - 07/2013
4	CytokinesIBA 01/2022 - 08/2013
4	Amino Acids FDA Link 09/2021 - 12/2009
4	Pharmaceutical PreparationsIBA 08/2021 - 08/2016
4	Brain-Derived Neurotrophic Factor (BDNF)IBA 12/2018 - 01/2015
4	Amyloid (Amyloid Fibrils)IBA 01/2018 - 08/2013
3	Aquaporin 4IBA 09/2022 - 01/2017
3	InflammasomesIBA 12/2021 - 12/2018
3	Biological ProductsIBA 01/2021 - 05/2014
3	1-phenyl-3,3-dimethyltriazene (PDT)IBA 11/2020 - 01/2019
3	Adenosine Diphosphate (ADP)IBA 01/2019 - 03/2016
3	SynaptophysinIBA 06/2018 - 03/2013
3	Amyloid Precursor Protein Secretases (beta-Secretase)IBA 12/2017 - 08/2013
3	Cholinergic Agents (Cholinergics)IBA 02/2012 - 10/2008
2	Sirtuin 3IBA 01/2022 - 12/2016
2	Interleukin-4 (Interleukin 4)IBA 01/2022 - 01/2016
2	Peptide Hydrolases (Proteases)FDA Link 01/2022 - 08/2016
2	VimentinIBA 02/2021 - 08/2016
2	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 10/2018
2	Fluorescent Dyes (Fluorescent Probes)IBA 01/2019 - 01/2018
2	Interleukin-6 (Interleukin 6)IBA 10/2018 - 11/2015
2	CholesterolIBA 06/2018 - 04/2012
2	EnzymesIBA 01/2018 - 07/2013
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2018 - 12/2005
2	Neuroprotective AgentsIBA 01/2016 - 01/2016
2	CalciumIBA 02/2015 - 05/2014
2	Cisplatin (Platino)FDA LinkGeneric 05/2014 - 01/2013
2	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 06/2013 - 12/2012
2	DNA (Deoxyribonucleic Acid)IBA 07/2012 - 10/2010
2	Hormones (Hormone)IBA 04/2012 - 02/2012
2	Estrogens (Estrogen)FDA Link 04/2008 - 04/2007
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 05/2022
1	calcipotriene (calcipotriol)FDA LinkGeneric 01/2022
1	Histone ChaperonesIBA 01/2022
1	Triiodothyronine (Liothyronine)FDA LinkGeneric 01/2022
1	Interleukin-13IBA 01/2022
1	Vascular Endothelial Growth Factor CIBA 01/2022
1	Long Noncoding RNAIBA 01/2022
1	mouse vascular endothelial growth factor CIBA 01/2022
1	SUMO-1 Protein (SUMO Protein)IBA 01/2022
1	MicroRNAs (MicroRNA)IBA 12/2021
1	Endoplasmic Reticulum Chaperone BiPIBA 08/2021
1	Dacarbazine (DIC)FDA LinkGeneric 02/2021

Therapy/Procedure

7	Therapeutics 08/2021 - 04/2006
5	Ovariectomy (Oophorectomy) 04/2012 - 04/2007
3	Ligation 01/2022 - 01/2019
3	Intravenous Injections 01/2021 - 01/2019
2	Transcranial Magnetic Stimulation 01/2022 - 07/2021
2	Photochemotherapy (Photodynamic Therapy) 11/2020 - 01/2019
2	Drug Therapy (Chemotherapy) 10/2018 - 12/2005
2	Injections 01/2018 - 01/2016
1	Hepatectomy 02/2021